BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15996071)

  • 1. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study.
    Chevalier X; Giraudeau B; Conrozier T; Marliere J; Kiefer P; Goupille P
    J Rheumatol; 2005 Jul; 32(7):1317-23. PubMed ID: 15996071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Chevalier X; Goupille P; Beaulieu AD; Burch FX; Bensen WG; Conrozier T; Loeuille D; Kivitz AJ; Silver D; Appleton BE
    Arthritis Rheum; 2009 Mar; 61(3):344-52. PubMed ID: 19248129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis.
    Richette P; François M; Vicaut E; Fitting C; Bardin T; Corvol M; Savouret JF; Rannou F
    J Rheumatol; 2008 Aug; 35(8):1650-4. PubMed ID: 18597398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
    Neustadt D; Caldwell J; Bell M; Wade J; Gimbel J
    J Rheumatol; 2005 Oct; 32(10):1928-36. PubMed ID: 16206349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.
    Theiler R; Brühlmann P
    Curr Med Res Opin; 2005 Nov; 21(11):1727-33. PubMed ID: 16307692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee.
    Day R; Brooks P; Conaghan PG; Petersen M;
    J Rheumatol; 2004 Apr; 31(4):775-82. PubMed ID: 15088306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of intra-articular sodium hyaluronate treatment in knee osteoarthritis patients who failed conservative treatment.
    Turajane T; Labpiboonpong V; Maungsiri S
    J Med Assoc Thai; 2007 Sep; 90(9):1839-44. PubMed ID: 17957928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.
    Auw Yang KG; Raijmakers NJ; van Arkel ER; Caron JJ; Rijk PC; Willems WJ; Zijl JA; Verbout AJ; Dhert WJ; Saris DB
    Osteoarthritis Cartilage; 2008 Apr; 16(4):498-505. PubMed ID: 17825587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee.
    Kolarz G; Kotz R; Hochmayer I
    Semin Arthritis Rheum; 2003 Apr; 32(5):310-9. PubMed ID: 12701041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and safety of intra-articular injection of sodium hyaluronate (500-730 kDa) in the treatment of patients with painful knee osteoarthritis.
    Phiphobmongkol V; Sudhasaneya V
    J Med Assoc Thai; 2009 Oct; 92(10):1287-94. PubMed ID: 19845235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.
    Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.